loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Ranolazine

    Menu

    Ranolazine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 83Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21526 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ranolazine(UNII: A6IEZ5M406)
    (ranolazine - UNII:A6IEZ5M406)     		ranolazine500mg

    Inactive Ingredients

    Ingredient Name
    Cardinal Health
    carnauba wax(R12CBM0EIZ)
    cellulose, microcrystalline(OP1R32D61U)
    ferric oxide red(1K09F3G675)
    ferric oxide yellow(EX438O2MRT)
    HYPROMELLOSE 2910 (5 MPA.S)(R75537T0T4)
    hypromelloses(3NXW29V3WO)
    magnesium stearate(70097M6I30)
    methacrylic acid - Ethyl Acrylate Copolymer (1:1) Type A(NX76LV5T8J)
    polyethylene glycol 3350(G2M7P15E5P)
    polyethylene glycol 400(B697894SGQ)
    POLYVINYL ALCOHOL(532B59J990)
    sodium hydroxide(55X04QC32I)
    TALC(7SEV7J4R1U)
    titanium dioxide(15FIX9V2JP)
    water(059QF0KO0R)